SIGACHINSE25 July 2025

Sigachi Industries Limited has informed the Exchange about Investor Presentation

Sigachi Industries Limited

Date: July 25, 2025

The Manager BSE Limited P. J. Towers, Dalal Street Mumbai-400001 (BSE Scrip Code: 543389)

The Manager National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex Bandra (E), Mumbai- 400051 (NSE Symbol: SIGACHI)

Dear Sir/Madam,

Sub: Investor Presentation for Q1 FY 2025-26 and Press Release

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015, and with reference to the subject cited, please find enclosed the Press Release and Investor Presentation for Q1 FY 2025-26. The same is also uploaded on the website of the Company www.sigachi.com

Request you to kindly take the same on record.

Thanking You,

Yours faithfully For Sigachi Industries Limited

Vivek Kumar Company Secretary & Compliance Officer

Sigachi Reports Q1 FY26 Results and Initiates Strategic Realignment Post Pashamylaram Unit Fire Incident

Hyderabad, 25th July 2025: Sigachi Industries Ltd. (NSE: SIGACHI; BSE: 543389), a leading global manufacturer of pharmaceutical excipients and active pharmaceutical ingredients (APIs), announced its financial results for the first quarter of FY26 and shared key updates following the fire incident at its Pashamylaram unit on 30th June 2025.

Sigachi reports reset of strategic priorities following Pashamylaram unit fire incident

Immediate response post-incident ensured minimal business disruption

• • Strategic review underway to realign operations with a renewed focus on safety,

sustainability, and growth

• FY26 guidance and Investor Presentation to reflect structural and cultural transformation

Q1 FY26 Financial Performance (INR MN)

PARTICULARS REVENUE GROSS PROFIT GROSS MARGIN (%) EBITDA EBITDA MARGIN (%) NET PROFIT / (LOSS)

Q1 FY26 ₹ 1,282 ₹ 547 42.64% ₹ 241 18.79% ₹ (1,010)

Q1 FY25 ₹ 957 ₹ 477 49.79% ₹ 210 21.94% ₹ 128

YOY (%) 33.99% 14.67% — — — —

Note: No deferred income from insurance claims has been considered in the reported results.

Updates on Q2 FY26 and strong FY26 guidance

• Production reallocated across Dahej and Jhagadia unit • Restoration and phased recommissioning to commence at Pashamylaram unit • Strong recovery expected in H2 FY26, driven by margin-focused product mix and

operational efficiency initiatives

Commenting on quarterly performance, Amit Raj Sinha, MD & CEO, Sigachi Industries Limited, said, "Q1 FY26 has been an emotionally and operationally challenging quarter for us. The tragic incident led to the loss of lives and injuries among our workforce, and we extend our deepest condolences to all affected. Our immediate focus was on supporting families, ensuring medical care, and cooperating fully with authorities. The incident disrupted manufacturing operations, damaged plant infrastructure and inventory, and delayed shipments, impacting revenue and margins. We activated emergency protocols, launched a detailed safety audit, and have

initiated phased restoration. While insurance claims have been filed, no deferred income has been accounted for. This event has prompted a comprehensive review of our operational controls and risk governance. Looking ahead, we are committed to a decisive reset, prioritizing safety, accelerating cost improvements, focusing on margin-led portfolios, and rebuilding with global standards, resilience, and transparency. With the lessons behind us and our resolve strengthened, we are confident in our ability to deliver sustainable growth and improve EBITDA margins.”

More details are given in Investor Presentation

For further information on the Company, please visit www.sigachi.com

About Sigachi Industries Ltd

Sigachi Industries Limited is a global player in the pharmaceutical industry dedicated to pioneering advancements in Active Pharmaceutical Ingredients (APIs), Intermediates, Excipients, vitamin-mineral blends, and Operations and Management (O&M) services. The company's diverse product portfolio is manufactured in 4 multilocational facilities, viz. Telangana, Gujarat, and Karnataka. Aligned with its ethos of customer centricity, Sigachi established subsidiaries in UAE and USA to be closer to its clients and improve responsiveness. With a strong focus on innovation, quality, and regulatory compliance, we leverage cutting-edge technology and global expertise to develop high-value pharma, food and nutrition solutions that enhance healthcare outcomes. Committed to excellence, we continuously invest in Research and Development, ensuring the highest standards of quality and safety. With 36 years of industry experience, Sigachi is a trusted partner for pharmaceutical and nutraceutical companies spread across 65+ countries. At Sigachi, we collaborate with healthcare partners, regulatory bodies, and global stakeholders to expand access to reliable, high-quality pharmaceutical ingredients.

Forward-Looking Statements

This press release contains forward-looking statements that reflect the current expectations and projections of Sigachi Industries Limited regarding future business performance, research and development initiatives, and strategic growth plans.

Forward-looking statements are generally identified by terms such as "aims," "expects," "intends," "plans," "believes," "seeks," "estimates," "potential," "future," and similar expressions. However, actual results may differ materially from those projected due to various risks and uncertainties, including but not limited to regulatory approvals, market dynamics, research outcomes, operational challenges, and broader economic or geopolitical factors.

Sigachi Industries Limited undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future developments, or otherwise, except as required by applicable laws.

SIGACHI INDUSTRIES LTD

Q 1 F Y 26 Investor Pres e nta tio n

2 5 t h J u l y ’ 2 0 2 5

Safe Harbour

No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. Certain statements made in this presentation may not be based on historical information or facts and may be "forward looking statements" based on the currently held beliefs and assumptions of the management of Sigachi Industries Limited (hereinafter referred to as “Sigachi” or “Company”), which are expressed in good faith and in their opinion reasonable, including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects and future developments in its industry and its competitive and regulatory environment. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company or industry results to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements, including future changes or developments in the Company’s business, its competitive environment and political, economic, legal and social conditions. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties and other factors, viewers of this presentation are cautioned not to place undue reliance on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements to reflect future events or developments. This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. This presentation does not constitute an offer or invitation to purchase or subscribe for any securities in any jurisdiction, including the United States. No part of it should form the basis of or be relied upon in connection with any investment decision or any contract or commitment to purchase or subscribe for any securities. None of our securities may be offered or sold in the United States, without registration under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption from registration there from. This presentation is confidential and may not be copied or disseminated, in whole or in part, and in any manner.

Agenda

01. Operational & Financial Highlights

03. Competitive Edge

02. Business Overview

04. Annexure

About Sigachi

PURPOSE

EXPERIENCE EXCELLENCE WITH OVER

WE ARE ONE OF THE

SIGACHI VALUES

To become the leading player in offering customized solutions, with the objective of creating a Healthier, Happier and Joyful World.

Year’s OF INDUSTRY LEADERSHIP

MISSION

GLOBAL REACH

PRODUCT RANGE

To be the best managed, fastest growing company, employing Innovation to deliver customized affordable solutions to the Pharma, Food, Nutrition and the Healthcare industry.

Sigachi believes in every stakeholder i.e. Customers, Suppliers, Employees, Shareholders and the Planet Earth to “Experience Excellence”.

PRODUCT AND SERVICE OFFERINGS

Purpose-Driven Customer Obsession

Unwavering Bias for Action

Leadership Through Extreme Ownership

Strength in Growth Mindset

PHARMACEUTICAL EXCIPIENTS

ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

FILM COATINGS

POLYMER BLENDS

FOOD & NUTRITION

OPERATIONS & MANAGEMENT

Excellence as One Team

A Quarter Marked by Loss, Guided by Responsibility

Q1 FY26 was a difficult quarter for Sigachi Industries. A tragic fire incident at our Pashamylaram facility in Telangana in June led to the heartbreaking loss of several valued team members. We extend our deepest condolences to the families affected. Our immediate focus has been on supporting the injured and grieving families, while fully cooperating with authorities in the ongoing investigation.

While this incident has deeply shaken us, we have responded with clarity and resolve. Recovery efforts are underway, supported by contingency planning and operational safeguards to limit further disruption. We remain engaged with stakeholders and authorities and are focused on stabilizing operations in a responsible and phased manner.

Mr. Amit Raj Sinha MD & CEO

Our Core Strengths and Capabilities

500 + Customers across 65+ Countries

5 State of the art facilities, strategically located in Hyderabad, Sultanpur, Jhagadia, Dahej & Raichur

Operating at a combined capacity of 24,000 MTPA across 4 strategic locations

Offering 100+ Products alongside tailored, customer centric solutions

Delivering consistent quality and tailored solutions to meet the evolving needs of our customers.

Global Presence

Manufacturing Facilities

Production Capacity

Product Range

Strong Customer Relationship

29%

35%

28%

Our facilities are accredited with EXCiPACT, WHO-GMP, GMP, SGMP, HACCP, EDQM CEP, FSSAI, USFDA, ISO 9001:2015 and more.

1800+ global employee base

5 Years Revenue CAGR

5 Years EBITDA CAGR

5 Years PAT CAGR

Quality Compliance

Employees

Operational and Financial Highlights

Business Overview

Competitive Edge Driving Profitability and Financial Stability

Annexure

Hyderabad Unit Accident – Business Impact

INCIDENT OVERVIEW  On 30th June, 2025,a dust explosion in the spray drying machine occurred at the Hyderabad Unit.  The incident resulted in 46 fatalities,8 unaccounted team members , with multiple injuries reported.  Operations at the affected unit have been temporarily suspended, damage assessment is ongoing

BUSINESS IMPACT

 Estimated revenue loss of Rs 60 crore over the closure period. Loss of profit during the closure period will be covered

by Business Interruption Policy.

 Operations at the 6400 MTPA Hyderabad Unit have been temporarily halted, impacting short-term production volumes. 

Strategic reallocation to other facilities in underway to stabilize output.



Sigachi is adequately insured for loss of profits. Insurance claims have been filed; no income from claims is recognized in Q1FY26 results.

RESPONSE & RECOVERY

 A full safety audit has been launched across all manufacturing sites.  Damage assessment and phased restoration are underway at the Hyderabad unit. Production has been reallocated to

other units, with operations at Dahej and Jhagadia continuing without disruption.

 Commenced making payments towards financial compensation and medical assistance for those affected by the

incident.

Operational Realignment for Sustainable Growth

Capacity Rebalancing & Business Continuity

Margin and Portfolio Optimization

Strategic Growth Initiatives on track

the

 Operations affected at Hyderabad been unit reallocated to Jhagadia and Dahej to ensure uninterrupted supply to key customers.

have



Streamlined shift planning and production schedules are in place demand effectively.

to manage

 Focused on prioritizing high- margin, demand-resilient products while deprioritizing low-throughput SKUs.

 This approach ensures efficient resource use and reduces supply chain pressure during recovery.

R&D to

center in commence

 New API Hyderabad operations—unifying development, and innovation under one roof to accelerate pipeline product delivery.

analytics,

 Continued focus on expanding and

exports MCC commercializing CCS.

IMPACT OF FIRE INCIDENT AT OUR HYDERABAD FACILITY

 The fire occurred on 30th June, 2025 at the Pashamylaram unit, Hyderabad caused by dust explosion in the spray drying machine.

 The incident

resulted in 46 fatalities, 8 unaccounted team members and 25 team members injured.

 Commenced making

payment

compensation

towards financial and medical assistance which includes ₹10 lakh each to 15 of 46 families as death compensation, ₹15 lakh each to families of 8 unaccounted team members and ₹1 lakh to 25 injured, with full medical support provided.

 Temporary disruption of operations caused production losses during the affected period.

Estimated revenue loss of Rs 60 crores over the closure period. Sigachi is adequately insured to cover this loss. No deferred income on account of insurance claims is considered in Q1 FY26 results.

 The fire incident occurred around 9:25 AM at our Hyderabad unit, triggered by a dust explosion in the spray drying section.

 A total of 46 fatalities, 8 unaccounted team members and 25

injured team members.

 Key operational zones,

including the spray dryer and adjoining quality control areas, sustained significant damage and remain non-operational pending full restoration.

 Preliminary estimates indicate a revenue impact of ₹ 60

Crores over the affected period.

 We remain deeply committed to employee wellbeing and being

corrective measures

continuity, with

business implemented across all facilities.

ESG Performance Q1 FY26

Progressing Towards A BETTER TOMORROW, Operating Responsibly Growing Sustainably

Environment (FY24-25)

•

Sustainably managed 99.98% of total waste reuse, through recycling, recovery, or authorized disposal Recycled withdrawn post operational use Key material issues identified as both Opportunities and Risks through recent Materiality Assessment

total water

19.76% of

Social

Social Employee Wellbeing • • •

80+ Blood Donors; World Blood Donor Day 94 new hires 9.6% gender diversity

Corporate Social Responsibility • Over 12,600+

lives touched

India

through CSR initiatives

Corporate Governance

Governance

•

100% Average Board meeting attendance 50% Independent board directors

Shareholders: Uninterrupted Value creation by Multiple diverse Business Verticals in the conglomerate

Customers: Increased trust on brands and Products owing to respected customer-first global avatar

People : Unlocks intrinsic motivation to explore various opportunities inside the system

Community: Larger expenditure towards CSR & Significant increase in ESG focus to achieve sustainability goals

Q1FY26 Financial Highlights

Revenue from Operational Income (Rs. Mn)

Rs. 1,282 Mn

33.99% YOY

EBITDA (Rs. Mn)

Rs. 241 Mn

14.76 % YOY

80%

75%

Revenue Contribution %

PAT (Rs. Mn)

Margins

Rs. (1,010) Mn

(789) % YOY

EBITDA : 18.79% (315) bps (YoY)

PAT : (78.78)% (9,216) bps (YoY)

11%

10%

MCC

Operations and Management

API

Allied Trades

Q1FY25

Q1FY26

Income Statement Q1 FY26

Particulars (Rs. Mn)

Revenue from Operational Income*

Total Expenses

EBITDA

EBITDA Margin

Depreciation and Amortization

Finance Cost

Other Income

Profit /(loss) before exceptional items

PBT Margin before exceptional items

Exceptional items

PBT

Tax Expense

PAT

PAT Margin

Other Comprehensive Income

Total Comprehensive Incomes

Basic EPS (Rs Per Share)

Diluted EPS (Rs Per Share)

Q1FY26

1,282

1,041

241

18.79%

200

15.60%

(1,210)

(1,010)

(78.78)%

(1,010)

(2.63)

QoQ

4.41)%

(15.43)%

(352) Bps

(11.89)%

(210) Bps

Q1FY25

YoY

957

747

210

33.99%

139.35%

14.76%

Q4FY25

1,282

997

285

21.94%

(315) Bps

22.31%

164

17.14%

128

13.38%

128

0.40

0.32

21.95%

(154)Bps

227

17.70%

162

12.63%

-4

158

0.36

0.39

Operational and Financial Highlights

Business Overview

Competitive Edge Driving Profitability and Financial Stability

Annexure

Sigachi Industries – Distinct Value Proposition

Sigachi Industries Ltd: Leading Manufacturer of Pre-Formulation Excipients

Presence in the Pharmaceutical Ecosystem

Competitive Edge

Largest MCC Manufacturing companies in India

Growth in API product portfolio and CEP Filings in pipeline

Present Across the Pharma Ecosystem

Pharma & Formulations

Pharma & API Intermediates

Pharma Excipients

Film Coatings, F&N Coatings

Formulators

Doctors

End Customers

Moving Up the Value chain by Introducing Value Added and Margin Accretive Products in the Product Basket

Research & Product Excellence

Advanced Manufacturing Facilities across 5 Strategic Locations

Focused on ensuring operational continuity through robust planning, consistent engagement with our partners and regulatory bodies

infrastructure

readiness,

and

Hyderabad Plant

Dahej SEZ Plant

Sultanpur Plant

Jhagadia Plant

Trimax Biosciences API Plant

Manufacturing Units o Five manufacturing facilities (Telangana, Gujarat, Karnataka) including SEZ and dedicated nutritional premix facility.

Expansion Plans

o Expanded Dahej, Jhagadia Capacities for MCC

o Setting up New Dahej

Unit for CCS

Research & Development

labs

state-of-the-art o Three in located R&D and Jhagadia Dahej, Hyderabad focusing on performance-oriented approaches and in-house technologies

Accredited Laboratory

o Laboratory

Dahej accredited by Department of Science and Industrial Research (DSIR).

Ongoing Commitment to R&D Investment

Trademarks

Patent Filed

Investment in Intellectual Properties : R&D (In Rs. Mn)

44.12

FY22

37.41

FY23

49.6

FY24

CEP

66.04

FY25

Quality Assurance: Certifications & Accreditation

Ensures quality control and assurance in all manufacturing units, with various certifications for processes and raw materials

Operational and Financial Highlights

Business Overview

Competitive Edge Driving Profitability and Financial Stability

Annexure

Achieving 3x Growth in Revenue and PAT Over a Period of 5 Years

Revenue (Rs. Mn)

EBITDA (Rs. Mn)

PAT (Rs. Mn)

PAT

20.1%

21.2%

19.4%

19.2%

22.4%

17.8%

16.0%

15.7%

5,088

4,106

14.6%

1,120

3,087

2,529

1,439

1,960

248

388

530

587

767

303

203

14.4%

14.3%

703

400

435

14.1%

572

FY20

FY21

FY22

FY23

FY24

FY25

FY20

FY21

FY22

FY23

FY24

FY25

FY20

FY21

FY22

FY23

FY24

FY25

Revenue (Rs. Mn)

EBITDA (Rs.Mn)

EBITDA Margin

PAT (Rs. Mn)

PAT Margin

Margin

EBITDA

PAT

5 Years CAGR (FY20-25)

5 Year Average Margin (FY20-25)

35%

28%

20.5%

14.9%

Nos. are consolidated basis

Low Debt: Maximizing Financial Stability

Gross Block (Rs. Mn)

Net Debt to Equity and Interest Coverage Ratio

3,456

2,157

416.5

FY20

503.3

FY21

1,151

682.5

FY22

FY23

FY24

FY25

45.31

0.28

FY20

10.56

31.04

0.02

FY21

13.68

0.03

0.13

FY22

FY23

FY24

0.04

FY25

5.56

-0.15

9.82

Net Debt to Equity

Interest Coverage Ratio

Cash Flow

To Drive Future Growth

Cash Flows from Operation (Rs. Mn)

Capex (Rs. Mn)

296

290

269

121

129

FY20

FY21

FY22

FY23

FY24

FY25

1,007

852

433

FY23

FY24

FY25

FY21

243

FY22

Operational and Financial Highlights

Business Overview

Competitive Edge Driving Profitability and Financial Stability

Annexure

Historical Income Statement

Particulars (Rs. Mn)

Revenue from Operational Income*

Total Expenses

EBITDA

EBITDA Margin

Depreciation and Amortisation

Finance costs

Other Income

PBT

PBT Margin

Tax Expense

PAT

PAT Margin

Other Comprehensive Income

Total Comprehensive Income

Basic EPS

Diluted EPS

FY21

1,928

1,540

388

FY22

2,503

1,972

531

20.12%

21.21%

385

20.0%

303

15.72%

304

1.31

516

20.6%

116

400

15.98%

-6

394

1.54

FY23

3,020

2,433

587

19.43%

545

18.0%

109

436

14.43%

437

1.41

FY24

3,989

3,223

766

19.20%

108

117

697

17.47%

125

572

14.34%

572

1.81

1.54

FY25

5,003

3,883

1,120

22.38%

158

124

923

18.44%

219

705

14.09%

-1

703

2.06

All numbers are on Consolidated Basis ; *FY25- Includes Rs.121 Mn as PLI Income

Historical Balance Sheet

Particulars (Rs. Mn)

NON-CURRENT ASSETS

a) Property, plant and equipment

b) Capital work-in-progress

c) Intangible assets

d) Goodwill

e) Right of Use Assets

f) Financial assets

i) Investments

ii) Other Financial Assets

g) Other non-current assets

CURRENT ASSETS

a) Financial Assets

i) Trade Receivables

ii) Cash and cash equivalents

iii) Bank balances other than above

iv) Other financial assets

b) Other current assets

c) Inventories

TOTAL ASSETS

All numbers are on Consolidated Basis

FY21

463

376

871

358

159

100

212

FY22

1,069

527

351

1,799

601

291

403

128

305

FY23

1,964

960

349

257

225

164

1,774

802

137

190

110

466

FY24

3,809

1,711

966

547

277

199

3,133

1,500

174

396

163

192

707

FY25

4,519

2,876

547

268

329

398

3,943

1,837

173

547

267

176

943

1,334

2,868

3,738

6,942

8,462

Historical Balance Sheet

Particulars (Rs. Mn)

EQUITY

Equity Share Capital

Other Equity

Equity attributable to the owners of the company

Minority Interest

NON-CURRENT LIABILITIES

a) Financial Liabilities

i) Borrowings

ii) Lease Liability

b) Provisions

c) Deferred tax liabilities (net)

CURRENT LIABILITIES

a) Financial Liabilities

i) Borrowings

ii) Lease Liabilities

iii) Trade Payables

iv) Other financial liabilities

b) Other current liabilities

c) Current tax liabilities (Net)

TOTAL LIABILITIES

TOTAL EQUITY AND LIABILITIES

All numbers are on Consolidated Basis

FY21

942

865

942

322

183

392

1,334

FY22

2,277

307

1,970

2,277

515

332

106

591

2,868

FY23

2,683

307

2,376

2,683

308

231

747

395

208

1,055

3,738

FY24

4,410

328

3,968

4,296

114

653

266

205

164

1,878

924

479

335

2,531

6,942

FY25

6,131

382

5,626

6,008

122

480

216

236

1,852

1,181

357

261

2,332

8,462

Key Milestones

1989 Incorporated as ‘Sigachi Chloro- Chemicals Private Limited

2000 o Launched premium-grade

MCC production

o Installed advanced spray drier

and multi-fuel furnace

o Capacity boosted from 720 to

1080 MTPA

2010

2014

Commenced the commercial production of MCC at manufacturing unit situated at Jhagadia

Merger of Sigachi Cellulose Private Limited and Sigachi Plasticizers Private Limited with the company

2023 Expanded Capacity to 21,000 MTPA, the Largest MCC Manufacturing

Company in India

2024 Sigachi MENA FZCO, a wholly owned subsidiary, has announced the formation of joint ventures, Sigachi Arabia and Sigachi Global.

1989

1998

2000

2009

2010

2012

2014

2021

2023

2024

2025

1998

Commenced its export operations by exporting its product

2009 Setting up of 100 % export oriented unit (“EOU”) for manufacturing MCC in the SEZ at Dahej, Gujarat

2012

Commenced the Commercial production of MCC at the manufacturing unit situated at Dahej

2021 Got listed on NSE & BSE on Nov 15, 2021

2023 Acquired Trimax Biosciences Pvt Ltd to expand into API product offerings

2025

Achieved GAIN (Global Alliance for Improved Nutrition) Audit Certification

Sigachi MENA FZCO, a wholly owned subsidiary, has formed a joint venture with Saudi National Projects Investment (SNP) to enter the growing Saudi Arabian market.

Strong Leadership

Distinct, high performing businesses aligned with business drivers and market requirements

Rabindra Prasad Sinha

Whole Time-Director & Chairman

Chidambarnathan Shanmuganathan

Whole Time-Director & Vice Chairman

Amit Raj Sinha

Managing Director & CEO

Subbarami Reddy Oruganti

Chief Financial Officer

Bhavani Chidambaranathan

President, Sigachi US, Inc.

Lijo Chacko

Deputy Group CEO

THANK YOU!

SIGACHI INDUSTRIES LTD

Corporate Office: Plot No. G 57/2, Survey no.70 & 174, Sultanpur Village, Patancheru Mandal, Hyderabad 502319, Sanga Reddy District, Telangana, India. Landline +918455242055/56/57

Registered office: 2nd floor, Kalyans Tulsiram Chambers, Madinaguda, Hyderabad 500049, Telangana, India. Landline +9140 40114874 /75/76

GO INDIA ADVISORS – IR FIRM

Ms. Priya Sen

Ms. Sana Kapoor

Ms. Sheetal Khanduja

priya@goindiaadvisors.com

sana@goindiaadvisors.com

M : +91 8334841047

M:+91 8146550469

sheetal@goindiaadvisors.com

M: +91 9769364166

← All Transcripts SIGACHI Stock Page →

Sigachi Industries Limited has informed the Exchange about Investor Presentation

Market Movers